Malek B. Hannouf
Calgary, AB T2N4N2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Real-World Effectiveness of Capecitabine and Temozolomide Across Endocrine and Neuroendocrine Neoplasm Subtypes (ENENs): A Population-Based Cohort Study from Alberta, Canada (2011-2021).
Journal: Current oncology (Toronto, Ont.)
Published: April 01, 2026
A Population-Based Study to Evaluate the Associations of Nodal Stage, Lymph Node Ratio and Log Odds of Positive Lymph Nodes with Survival in Patients with Small Bowel Adenocarcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: January 21, 2022
Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma.
Journal: Canadian liver journal
Published: January 12, 2022
Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer.
Journal: Cancer treatment and research communications
Published: March 02, 2021
Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008-2012.
Journal: Current oncology (Toronto, Ont.)
Published: December 09, 2020
Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study.
Journal: Breast (Edinburgh, Scotland)
Published: July 07, 2020
Real-world Safety and Efficacy of Raltitrexed in Patients With Metastatic Colorectal Cancer.
Journal: Clinical colorectal cancer
Published: May 25, 2020
Letter to the Editor.
Journal: Journal of comparative effectiveness research
Published: November 20, 2019
Survival outcome differences based on treatments used and knowledge of the primary tumour site for patients with cancer of unknown and known primary in Ontario.
Journal: Current oncology (Toronto, Ont.)
Published: November 23, 2018
The evolution of biosimilars in oncology, with a focus on trastuzumab.
Journal: Current oncology (Toronto, Ont.)
Published: June 19, 2018
Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.
Journal: The pharmacogenomics journal
Published: May 30, 2018
Last Updated: 09/26/2026